Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Mount Sinai Journal of Medicine, New York|January 27, 2010
Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's DiseaseAlex L Lublin, Sam Gandy
Developmental Biology|January 20, 2007
The RNA-binding proteins PUF-5, PUF-6, and PUF-7 reveal multiple systems for maternal mRNA regulation during C. elegans oogenesisAlex L Lublin, Thomas C Evans
Current Biology : CB|September 13, 2002
A novel function for the Sm proteins in germ granule localization during C. elegans embryogenesisScott A Barbee, Alex L Lublin, Thomas C Evans
Mechanisms of Ageing and Development|December 9, 2008
SOD isoforms play no role in lifespan in ad lib or dietary restricted conditions, but mutational inactivation of SOD-1 reduces life extension by coldKelvin Yen, Harshil B Patel, Alex L Lublin, et al.
Frontiers in Neurology|March 17, 2022
Vaccine Response in Patients With Multiple Sclerosis Receiving TeriflunomideCarlo Tornatore, Heinz Wiendl, Alex L Lublin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 9, 2014
Nordihydroguaiaretic Acid Extends the Lifespan of Drosophila and Mice, Increases Mortality-Related Tumors and Hemorrhagic Diathesis, and Alters Energy Homeostasis in MiceStephen R Spindler, Patricia L Mote, Alex L Lublin, et al.
Biochemistry and Biophysics Reports|November 28, 2022
In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43Paul Lang, Svend S Geertsen, Alex L Lublin, et al.
Age (Dordrecht, Netherlands)|January 15, 2013
β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived miceStephen R Spindler, Patricia L Mote, Rui Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 12, 2023
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trialJens Kuhle, Tanuja Chitnis, Brenda Banwell, et al.
Multiple Sclerosis and Related Disorders|September 10, 2020
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension studyAaron E Miller, Tomas P Olsson, Jerry S Wolinsky, et al.
Pageof 2